High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
ACTIVE_NOT_RECRUITING
Status
Conditions
- Plasma Cell Leukemia
- Recurrent Multiple Myeloma
- Refractory Multiple Myeloma
Interventions
- PROCEDURE: Biospecimen Collection
- DEVICE: High Throughput Screening
- OTHER: Laboratory Biomarker Analysis
Sponsor
University of Washington